InsiderTrades

Form 4 for GH Guardant Health, Inc.

Accepted 2025-09-03 00:00:00 ET · period of report 2025-09-01 · accession 0001927831-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-09-03 2025-09-01 GH Kalia Kumud CIO M - OptEx $0.00 +711 19.2K +4% $0
D 2025-09-03 2025-09-01 GH Kalia Kumud CIO F - Tax $67.42 -361 18.9K -2% -$24.3K
D 2025-09-03 2025-09-01 GH Kalia Kumud CIO M - OptEx $0.00 -711 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-09-01 M A 711 $0.00 19,211 D — —
2 Common Common Stock 2025-09-01 F D 361 $67.42 18,850 D — — (F1) Not applicable for Restricted Stock Units.
3 Derivative Restricted Stock Units 2025-09-01 M D 711 $0.00 0 D $0.00 · — to — 711 Common Stock (F2) The restricted stock unit award was granted on November 2, 2021, and vested 25% of the shares subject to such award on September 1, 2022. The remaining 75% of the shares subject to such award vests in equal installments on each quarterly anniversary of September 1, 2022 during the three-year period thereafter. (F1) Not applicable for Restricted Stock Units.